Market Place
Sourcing Support
Suven Pharmaceuticals Q2 FY25 revenue grows 12% in Q2
13 Nov 2024 //
INDPHARMAPOST
Suven, Cohance to Double Business Revenue to Rs 6,000 Cr by FY29
01 Nov 2024 //
ECONOMICTIMES
Suven, Cohance Aim to Double Revenue to Rs 6,000 Cr by FY29
01 Nov 2024 //
ECONOMICTIMES
Casper Pharma`s Merger with Suven Pharma Cleared by NCLT
30 Oct 2024 //
ECONOMICTIMES
Casper Pharma Merger with Suven Pharmaceuticals Cleared
30 Oct 2024 //
ECONOMICTIMES
Suven Pharmaceuticals names Vivek Sharma as executive chairman
19 Sep 2024 //
ETTIMES
Cohance Lifesciences merger with Suven Pharma gets NSE, BSE nod
27 Jul 2024 //
TIMESOFINDIA
CCI approves two acquisitions involving Arjas Steel, Suven Pharmaceutical
19 Jul 2024 //
ECONOMICTIMES
Suven gets Form 483 from with two observations from USFDA for Casper Pharma
14 Jul 2024 //
INDIANPHARMAPOST
Suven to acquire a majority stake in CDMO player ‘Sapala Organics’
13 Jun 2024 //
PRESS RELEASE
Suven Pharma to acquire controlling stake in Hyderabad-based CDMO Sapala Organic
13 Jun 2024 //
ECONOMICTIMES
Suven, with Cohance and more, wants to become a CDMO powerhouse
02 Mar 2024 //
ECONOMIC TIMES
Suven-Cohance Lifesciences merger announced
29 Feb 2024 //
PRESS RELEASE
Suven Pharmaceuticals receives US FDA nod for Hyderabad units
23 Feb 2024 //
CNBCTV18
PE Advent completes acquisition of Suven Pharma
29 Sep 2023 //
ECONOMIC TIMES
Cabinet clears Advent`s acquisition of Suven Pharma for Rs 9,589 crore
14 Sep 2023 //
ECONOMIC TIMES
CCI clears Berhyanda`s acquisition of Suven Pharma
22 Apr 2023 //
HEALTH ET
Advent International to acquire a significant stake in Suven Pharmaceuticals
26 Dec 2022 //
INDIANPHARMAPOST
Blackstone, Advent International in talks to buy controlling stake in Suven
03 Nov 2022 //
MONEYCONTROL
Suven Pharma says Casper Pharma completes USFDA pre-approval inspection
30 Jul 2022 //
BUSINESS-STANDARD
Suven Pharm`s Generic Glycopyrrolate Receives Approval in the U.S.
05 Jul 2022 //
FDA
Suven Pharma acquires Hyderabad-based formulation maker for Rs 155 crore
06 Apr 2022 //
ECONOMIC TIMES
Suven Pharma gains 5% to hit record high; stock rallies 18% in three days
24 Mar 2022 //
BUSINESS-STANDARD
Suven Pharms`s Generic Chloroquine Phosphate Receives Approval in the US
03 Sep 2021 //
FDA
CSIR-IICT, NIIST, Suven Pharma sign MoU for Molnupiravir
10 Jun 2021 //
EXPRESS PHARMA
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.